PARADROMICS

In News

Austin's Paradromics advances Brain-Computer Interface with successful surgery - MSN

MSN - Feb 12, 2026

Paradromics Gets FDA Approval to Trial Its Brain Implant in People - WIRED

WIRED - Nov 20, 2025

FDA approves Paradromics’ brain-computer interface trial for speech restoration - statnews.com

statnews.com - Nov 20, 2025

Paradromics Secures FDA Approval for Innovative Brain-Computer Interface Study - SynBioBeta

SynBioBeta - Nov 20, 2025

Neuralink competitor Paradromics completes first human implant - CNBC

CNBC - Jun 02, 2025

Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface - Business Wire

Business Wire - Nov 20, 2025

Austin brain implant firm gets FDA approval for first long-term clinical trial - Austin American-Statesman

Austin American-Statesman - Nov 25, 2025

Fully implantable brain chip aims to restore real speech - Kurt the CyberGuy

Kurt the CyberGuy - Feb 12, 2026

Paradromics gets FDA green light for BCI study - massdevice.com

massdevice.com - Nov 20, 2025

Paradromics Joins Neurotech Race With FDA Nod To Test BCI For Restoring Speech - Citeline News & Insights

Citeline News & Insights - Dec 02, 2025

Neuralink rival Paradromics cleared to start speech trial - pharmaphorum

pharmaphorum - Nov 21, 2025

Austin-based neurotechnology company completes first implantation of brain-computer device in a human - KVUE

KVUE - Jun 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment